Calcitonin-Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention; Literature Review
2021; Volume: 10; Issue: 1 Linguagem: Inglês
10.51847/ogc7ozojph
ISSN2277-8047
AutoresHaneen Ahmed Khouja, Rawan Awadh Alshehri, Hussain Mirza Alhalal, Hassan Dhafer Alabisi, Salhah Mohammad Alajmi, Zahra Moneer Al Radi, Zainab Abduljabbar Al Hamoud, Asma Wadi Zaid Alshammari, Danah Youssef A Albouri,
Tópico(s)Dental Anxiety and Anesthesia Techniques
ResumoMigraine is one of the most common disabling disorders worldwide that influence the patient functionality and quality of life. Current preventive therapy has succeeded in preventing and decreasing migraine days; however, unwanted adverse effects are considered a serious issue and can lead to discontinuation of the medication. The calcitonin-gene-related peptide is a neuropeptide that plays a major role in migraine pathogenesis, and inhibiting this peptide is thought to achieve a therapeutic role
Referência(s)